These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6786460)

  • 21. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy.
    Yildizdas D; Erdem S; Küçükosmanoglu O; Yilmaz M; Yüksel B
    Adv Ther; 2008 May; 25(5):515-9. PubMed ID: 18512033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature.
    Hughes JD; Rubin LJ
    Medicine (Baltimore); 1986 Jan; 65(1):56-72. PubMed ID: 2867454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antihypertensive therapy with diazoxide during anaesthesia (author's transl)].
    Franke N; Martin E; van Ackern K; Schmucker P; Kreuzer E
    Anaesthesist; 1980 Jun; 29(6):333-6. PubMed ID: 7406205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.
    Timlin MR; Black AB; Delaney HM; Matos RI; Percival CS
    Pediatr Cardiol; 2017 Aug; 38(6):1247-1250. PubMed ID: 28642988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of diazoxide on the functional state of the heart].
    Dubov PB; Klembovskiĭ AA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):93. PubMed ID: 6639764
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of peripheral blood circulation values in hypertension following diazoxide administration].
    Bahlmann J; Brod J; Cachovan M; Celsen B; Sippel R
    Verh Dtsch Ges Inn Med; 1975; 81():1049-51. PubMed ID: 1229395
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemodynamic evaluation of nifedipine in primary pulmonary hypertension--short and long term effects].
    Yamaguchi S; Tsuiki K; Hayasaka M; Oguma M; Ohta I; Kaminishi T; Sukekawa H; Kanaya T; Yasui S
    Kokyu To Junkan; 1986 Feb; 34(2):171-6. PubMed ID: 3704359
    [No Abstract]   [Full Text] [Related]  

  • 28. Diazoxide in the management of severe hypertension.
    Moller BB; Kolendorf K
    Acta Med Scand; 1975 Nov; 198(5):358-8. PubMed ID: 1199811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The case for treatment of selected patients with primary pulmonary hypertension.
    Reeves JT; Groves BM; Turkevich D
    Am Rev Respir Dis; 1986 Aug; 134(2):342-6. PubMed ID: 3740659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol.
    Pietro DA; LaBresh KA; Shulman RM; Folland ED; Parisi AF; Sasahara AA
    N Engl J Med; 1984 Apr; 310(16):1032-4. PubMed ID: 6708977
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term use of the calcium antagonist nifedipine (corinfar) in the treatment of patients with primary pulmonary hypertension].
    Khosseĭn A; Mukharliamov NM; Mareev VIu; Lobova NM; Ageev FT
    Kardiologiia; 1988 Apr; 28(4):54-8. PubMed ID: 3292811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term oral diazoxide therapy for pulmonary vascular obstructive disease associated with congenital heart defects.
    Rao PS
    Am Heart J; 1990 Jun; 119(6):1317-21. PubMed ID: 2353618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness of continuous intravenous prostaglandin E 1 against pulmonary hypertension].
    Satomi K; Satoh T; Kyotani S; Fukushima S; Okano Y; Nakanishi N; Kunieda T
    Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):421-7. PubMed ID: 9742857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypoxic pulmonary hypertension: nifedipine therapy].
    Agostoni P; Doria E; Galli C; Tamborini G; Fiorentini C; Guazzi M
    Cardiologia; 1988 Oct; 33(10):961-9. PubMed ID: 3233606
    [No Abstract]   [Full Text] [Related]  

  • 35. Diazoxide.
    Koch-Weser J
    N Engl J Med; 1976 Jun; 294(23):1271-3. PubMed ID: 772431
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of the hypertensive crises. Experience with diazoxide].
    Ocón Pujadas J; Herrera Pérez de Villar J; Belvis Mompel JJ; García Muñóz P
    Rev Clin Esp; 1975 Mar; 136(5):473-82. PubMed ID: 1135461
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of the calcium antagonist nifedipine on central and peripheral hemodynamics in patients with primary pulmonary hypertension].
    Khosseĭn A; Mareev VIu; Ageev FT; Sazonova LN; Lobova NM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):78-81. PubMed ID: 3401345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of diazoxide in hypertension with renal failure.
    Pohl JE; Thurston H
    Br Med J; 1971 Oct; 4(5780):142-5. PubMed ID: 5113016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nitrates in the treatment of hypoxic pulmonary hypertension].
    Hamet A; Král B; Cernohorský D; Gregor J; Pospísil M; Tilser P; Eliás J; Rozánek P; Koudelka V
    Vnitr Lek; 1987 Apr; 33(4):332-40. PubMed ID: 3109117
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of vasodilators on pulmonary hypertension].
    Uotani K; Kanamori K; Fujimura M; Mifune J; Taga K; Shimizu M; Hifumi S; Takahashi Y; Azuma H; Tanaka T
    Kokyu To Junkan; 1986 Sep; 34(9):977-83. PubMed ID: 3786964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.